INTRODUCTION: Biliary atresia (BA) is the leading indication for liver transplantation in the pediatric population. The murine model of BA supports a viral etiology, because infection of neonatal mice with rhesus rotavirus (RRV) results in biliary obstruction. Viral infection targets the biliary epithelium and development of the model is viral strain dependent. No study has yet determined whether human cholangiocytes are also susceptible to rotaviral infection. We established an in vitro human model using an immortalized human cholangiocyte cell line and primary human cholangiocytes obtained from explanted livers to determine human cholangiocyte susceptibility to rotavirus infection. METHODS: Replication and binding assays were performed on immortalized mouse (mCL) and human (H69) cells using six different strains of rotavirus. Primary human cholangiocytes were isolated from cadaveric livers, characterized in culture, and infected with RRV, which causes BA in mice, and another simian strain, TUCH, which does not cause BA in mice. RESULTS: Immortalized mouse and human cholangiocytes demonstrated similar patterns of infectivity and binding with different strains of rotavirus. Both cell lines produced a significantly higher viral yield with RRV infection than with the other strains tested. In primary human cholangiocytes, which maintained their epithelial characteristics, as demonstrated by cytokeratin staining, RRV replicated to a yield 1000-fold higher than TUCH. CONCLUSIONS: Both immortalized and primary human cholangiocytes are susceptible to RRV infection in a fashion similar to murine cholangiocytes. These novel findings suggest rotavirus infection could have a potential role in the pathogenesis of human BA.
INTRODUCTION:Biliary atresia (BA) is the leading indication for liver transplantation in the pediatric population. The murine model of BA supports a viral etiology, because infection of neonatalmice with rhesus rotavirus (RRV) results in biliary obstruction. Viral infection targets the biliary epithelium and development of the model is viral strain dependent. No study has yet determined whether human cholangiocytes are also susceptible to rotaviral infection. We established an in vitro human model using an immortalized human cholangiocyte cell line and primary human cholangiocytes obtained from explanted livers to determine human cholangiocyte susceptibility to rotavirus infection. METHODS: Replication and binding assays were performed on immortalized mouse (mCL) and human (H69) cells using six different strains of rotavirus. Primary human cholangiocytes were isolated from cadaveric livers, characterized in culture, and infected with RRV, which causes BA in mice, and another simian strain, TUCH, which does not cause BA in mice. RESULTS: Immortalized mouse and human cholangiocytes demonstrated similar patterns of infectivity and binding with different strains of rotavirus. Both cell lines produced a significantly higher viral yield with RRV infection than with the other strains tested. In primary human cholangiocytes, which maintained their epithelial characteristics, as demonstrated by cytokeratin staining, RRV replicated to a yield 1000-fold higher than TUCH. CONCLUSIONS: Both immortalized and primary human cholangiocytes are susceptible to RRV infection in a fashion similar to murine cholangiocytes. These novel findings suggest rotavirus infection could have a potential role in the pathogenesis of human BA.
Authors: M Riepenhoff-Talty; V Gouvea; M J Evans; L Svensson; E Hoffenberg; R J Sokol; I Uhnoo; S J Greenberg; K Schäkel; G Zhaori; J Fitzgerald; S Chong; M el-Yousef; A Nemeth; M Brown; D Piccoli; J Hyams; D Ruffin; T Rossi Journal: J Infect Dis Date: 1996-07 Impact factor: 5.226
Authors: Pranavkumar Shivakumar; Kathleen M Campbell; Gregg E Sabla; Alexander Miethke; Greg Tiao; Monica M McNeal; Richard L Ward; Jorge A Bezerra Journal: J Clin Invest Date: 2004-08 Impact factor: 14.808
Authors: M Riepenhoff-Talty; K Schaekel; H F Clark; W Mueller; I Uhnoo; T Rossi; J Fisher; P L Ogra Journal: Pediatr Res Date: 1993-04 Impact factor: 3.756
Authors: Sarah E Blutt; Carl D Kirkwood; Viviana Parreño; Kelly L Warfield; Max Ciarlet; Mary K Estes; Karin Bok; Ruth F Bishop; Margaret E Conner Journal: Lancet Date: 2003-11-01 Impact factor: 79.321
Authors: Nirmala Mavila; David James; Pranavkumar Shivakumar; Marie V Nguyen; Sarah Utley; Katrina Mak; Allison Wu; Shengmei Zhou; Larry Wang; Christopher Vendyres; Megan Groff; Kinji Asahina; Kasper S Wang Journal: Hepatology Date: 2014-07-17 Impact factor: 17.425
Authors: Marianita Santiana; Sourish Ghosh; Brian A Ho; Vignesh Rajasekaran; Wen-Li Du; Yael Mutsafi; Dennise A De Jésus-Diaz; Stanislav V Sosnovtsev; Eric A Levenson; Gabriel I Parra; Peter M Takvorian; Ann Cali; Christopher Bleck; Anastasia N Vlasova; Linda J Saif; John T Patton; Patrizia Lopalco; Angela Corcelli; Kim Y Green; Nihal Altan-Bonnet Journal: Cell Host Microbe Date: 2018-08-08 Impact factor: 21.023
Authors: Li Yang; Pranavkumar Shivakumar; Jeremy Kinder; Sing Sing Way; Bryan Donnelly; Reena Mourya; Zhenhua Luo; Jorge A Bezerra Journal: JCI Insight Date: 2020-06-04
Authors: Jessica A Zagory; Michael Fenlon; William Dietz; Menghan Zhao; Marie V Nguyen; Pavin Trinh; Maeva Adoumie; Alex Park; Jiabo Xu; Elaa Mahdi; Alison Glazier; Nicolas Malkoff; Nirmala Mavila; Kasper S Wang Journal: Hepatology Date: 2019-04-11 Impact factor: 17.425
Authors: Maria Grazia Clemente; John T Patton; Robert A Anders; Robert H Yolken; Kathleen B Schwarz Journal: Biomed Res Int Date: 2015-07-13 Impact factor: 3.411